Follow the people · Insider
Brian C. Stephenson
Brian C. Stephenson files insider transactions with the SEC as a chief financial officer of Faeth Therapeutics (FTH). We hold 7 disclosed purchases and sales filed since 3 July 2019, 7 of them in the last 90 days.
- Files forFTH
- Disclosed buys and sells7 in all, 7 in the last 90 days
- Last disclosure1 July 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 June 2026 — 1 July 2026Chief Financial Officer · Faeth Therapeutics (FTH)22 Form 4 lines · source: SEC Form 4
- Filed 1 July 2019 — 25 February 2025CFO and Treasurer · BridgeBio Pharma (BBIO)169 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 831 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▲ bought on the open market 1,910 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▲ bought on the open market 1,638 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▲ bought on the open market 4,255 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▲ bought on the open market 4,400 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- ▲ bought on the open market 600 shares of Faeth TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- ▲ bought on the open market 2,891 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- ▲ bought on the open market 3,000 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- ▲ bought on the open market 3,400 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- ▲ bought on the open market 100 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- ▲ bought on the open market 580 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▲ bought on the open market 4,212 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▲ bought on the open market 1,358 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▲ bought on the open market 100 shares of Faeth TherapeuticsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▲ bought on the open market 1,797 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▲ bought on the open market 1,118 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▲ bought on the open market 1,583 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▲ bought on the open market 3,329 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▲ bought on the open market 356 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 22 June 2026 · filed 24 June 2026
- ▲ bought on the open market 6,836 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▲ bought on the open market 1,969 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- ▲ bought on the open market 425 shares of Faeth TherapeuticsSEC Form 424 June 2026Common Stock · traded 23 June 2026 · filed 24 June 2026
- exercised options over 8,500 shares of BridgeBio Pharma (a derivative holding)SEC Form 427 February 2025Stock Option (right to buy) · traded 25 February 2025 · filed 27 February 2025
- exercised options over 8,500 shares of BridgeBio PharmaSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- ▼ sold on the open market 8,400 shares of BridgeBio PharmaSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- ▼ sold on the open market 100 shares of BridgeBio PharmaSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- exercised options over 779 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 946 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 6,705 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 16 February 2025 · filed 19 February 2025
- exercised options over 25,798 shares of BridgeBio PharmaSEC Form 419 February 2025Common Stock · traded 16 February 2025 · filed 19 February 2025
- had shares withheld for tax on 13,102 shares of BridgeBio PharmaSEC Form 419 February 2025Common Stock · traded 16 February 2025 · filed 19 February 2025
- ▼ sold on the open market 4,148 shares of BridgeBio PharmaSEC Form 419 February 2025Common Stock · traded 19 February 2025 · filed 19 February 2025
- exercised options over 68,000 shares of BridgeBio Pharma (a derivative holding)SEC Form 430 January 2025Stock Option (right to buy) · traded 28 January 2025 · filed 30 January 2025
- exercised options over 68,000 shares of BridgeBio PharmaSEC Form 430 January 2025Common Stock · traded 28 January 2025 · filed 30 January 2025
- ▼ sold on the open market 68,000 shares of BridgeBio PharmaSEC Form 430 January 2025Common Stock · traded 28 January 2025 · filed 30 January 2025
- was granted 42,683 shares of BridgeBio Pharma (a derivative holding)SEC Form 412 December 2024Restricted Stock Units · traded 10 December 2024 · filed 12 December 2024
- ▼ sold on the open market 4,156 shares of BridgeBio PharmaSEC Form 420 November 2024Common Stock · traded 19 November 2024 · filed 20 November 2024
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 16 November 2024 · filed 19 November 2024
- exercised options over 947 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 16 November 2024 · filed 19 November 2024
- exercised options over 17,369 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 16 November 2024 · filed 19 November 2024
- exercised options over 6,705 shares of BridgeBio Pharma (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 16 November 2024 · filed 19 November 2024
- exercised options over 25,799 shares of BridgeBio PharmaSEC Form 419 November 2024Common Stock · traded 16 November 2024 · filed 19 November 2024
- had shares withheld for tax on 13,077 shares of BridgeBio PharmaSEC Form 419 November 2024Common Stock · traded 16 November 2024 · filed 19 November 2024
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 August 2024Restricted Stock Units · traded 16 August 2024 · filed 20 August 2024
- exercised options over 946 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 August 2024Restricted Stock Units · traded 16 August 2024 · filed 20 August 2024
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 August 2024Restricted Stock Units · traded 16 August 2024 · filed 20 August 2024
- exercised options over 6,705 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 August 2024Restricted Stock Units · traded 16 August 2024 · filed 20 August 2024
- exercised options over 25,797 shares of BridgeBio PharmaSEC Form 420 August 2024Common Stock · traded 16 August 2024 · filed 20 August 2024
- had shares withheld for tax on 13,077 shares of BridgeBio PharmaSEC Form 420 August 2024Common Stock · traded 16 August 2024 · filed 20 August 2024
- ▼ sold on the open market 2,457 shares of BridgeBio PharmaSEC Form 420 August 2024Common Stock · traded 19 August 2024 · filed 20 August 2024
- ▼ sold on the open market 1,698 shares of BridgeBio PharmaSEC Form 420 August 2024Common Stock · traded 19 August 2024 · filed 20 August 2024
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 16 May 2024 · filed 17 May 2024
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 16 May 2024 · filed 17 May 2024
- exercised options over 947 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 16 May 2024 · filed 17 May 2024
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 16 May 2024 · filed 17 May 2024
- exercised options over 6,704 shares of BridgeBio Pharma (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 16 May 2024 · filed 17 May 2024
- exercised options over 27,507 shares of BridgeBio PharmaSEC Form 417 May 2024Common Stock · traded 16 May 2024 · filed 17 May 2024
- had shares withheld for tax on 13,943 shares of BridgeBio PharmaSEC Form 417 May 2024Common Stock · traded 16 May 2024 · filed 17 May 2024
- was granted 15,442 shares of BridgeBio Pharma (a derivative holding)SEC Form 414 March 2024Stock Option (right to buy) · traded 12 March 2024 · filed 14 March 2024
- was granted 107,278 shares of BridgeBio Pharma (a derivative holding)SEC Form 414 March 2024Restricted Stock Units · traded 12 March 2024 · filed 14 March 2024
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- exercised options over 946 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- exercised options over 17,369 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2024Restricted Stock Units · traded 16 February 2024 · filed 21 February 2024
- exercised options over 44,996 shares of BridgeBio PharmaSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- had shares withheld for tax on 18,919 shares of BridgeBio PharmaSEC Form 421 February 2024Common Stock · traded 16 February 2024 · filed 21 February 2024
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 November 2023Restricted Stock Units · traded 16 November 2023 · filed 20 November 2023
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 November 2023Restricted Stock Units · traded 16 November 2023 · filed 20 November 2023
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 November 2023Restricted Stock Units · traded 16 November 2023 · filed 20 November 2023
- exercised options over 947 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 November 2023Restricted Stock Units · traded 16 November 2023 · filed 20 November 2023
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 420 November 2023Restricted Stock Units · traded 16 November 2023 · filed 20 November 2023
- exercised options over 44,996 shares of BridgeBio PharmaSEC Form 420 November 2023Common Stock · traded 16 November 2023 · filed 20 November 2023
- had shares withheld for tax on 22,311 shares of BridgeBio PharmaSEC Form 420 November 2023Common Stock · traded 16 November 2023 · filed 20 November 2023
- ▼ sold on the open market 22,685 shares of BridgeBio PharmaSEC Form 420 November 2023Common Stock · traded 17 November 2023 · filed 20 November 2023
- exercised options over 1,709 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 946 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2023Restricted Stock Units · traded 16 August 2023 · filed 18 August 2023
- exercised options over 44,994 shares of BridgeBio PharmaSEC Form 418 August 2023Common Stock · traded 16 August 2023 · filed 18 August 2023
- had shares withheld for tax on 22,311 shares of BridgeBio PharmaSEC Form 418 August 2023Common Stock · traded 16 August 2023 · filed 18 August 2023
- ▼ sold on the open market 22,683 shares of BridgeBio PharmaSEC Form 418 August 2023Common Stock · traded 17 August 2023 · filed 18 August 2023
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2023Restricted Stock Units · traded 16 May 2023 · filed 18 May 2023
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2023Restricted Stock Units · traded 16 May 2023 · filed 18 May 2023
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2023Restricted Stock Units · traded 16 May 2023 · filed 18 May 2023
- exercised options over 947 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2023Restricted Stock Units · traded 16 May 2023 · filed 18 May 2023
- exercised options over 17,368 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2023Restricted Stock Units · traded 16 May 2023 · filed 18 May 2023
- exercised options over 44,996 shares of BridgeBio PharmaSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- had shares withheld for tax on 20,572 shares of BridgeBio PharmaSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- ▼ sold on the open market 24,424 shares of BridgeBio PharmaSEC Form 418 May 2023Common Stock · traded 17 May 2023 · filed 18 May 2023
- ▼ sold on the open market 64,929 shares of BridgeBio PharmaSEC Form 45 May 2023Common Stock · traded 3 May 2023 · filed 5 May 2023
- ▼ sold on the open market 55,500 shares of BridgeBio PharmaSEC Form 47 April 2023Common Stock · traded 5 April 2023 · filed 7 April 2023
- ▼ sold on the open market 62,692 shares of BridgeBio PharmaSEC Form 43 March 2023Common Stock · traded 3 March 2023 · filed 3 March 2023
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2023Restricted Stock Units · traded 16 February 2023 · filed 21 February 2023
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2023Restricted Stock Units · traded 16 February 2023 · filed 21 February 2023
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2023Restricted Stock Units · traded 16 February 2023 · filed 21 February 2023
- exercised options over 946 shares of BridgeBio Pharma (a derivative holding)SEC Form 421 February 2023Restricted Stock Units · traded 16 February 2023 · filed 21 February 2023
- exercised options over 27,627 shares of BridgeBio PharmaSEC Form 421 February 2023Common Stock · traded 16 February 2023 · filed 21 February 2023
- had shares withheld for tax on 9,910 shares of BridgeBio PharmaSEC Form 421 February 2023Common Stock · traded 16 February 2023 · filed 21 February 2023
- ▼ sold on the open market 15,567 shares of BridgeBio PharmaSEC Form 421 February 2023Common Stock · traded 17 February 2023 · filed 21 February 2023
- ▼ sold on the open market 2,150 shares of BridgeBio PharmaSEC Form 421 February 2023Common Stock · traded 17 February 2023 · filed 21 February 2023
- was granted 323,431 shares of BridgeBio Pharma (a derivative holding)SEC Form 414 February 2023Stock Option (Right to Buy) · traded 10 February 2023 · filed 14 February 2023
- was granted 277,893 shares of BridgeBio Pharma (a derivative holding)SEC Form 414 February 2023Restricted Stock Units · traded 10 February 2023 · filed 14 February 2023
- ▼ sold on the open market 61,040 shares of BridgeBio PharmaSEC Form 46 February 2023Common Stock · traded 3 February 2023 · filed 6 February 2023
- ▼ sold on the open market 61,040 shares of BridgeBio PharmaSEC Form 46 January 2023Common Stock · traded 5 January 2023 · filed 6 January 2023
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 November 2022Restricted Stock Units · traded 16 November 2022 · filed 18 November 2022
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 November 2022Restricted Stock Units · traded 16 November 2022 · filed 18 November 2022
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 November 2022Restricted Stock Units · traded 16 November 2022 · filed 18 November 2022
- exercised options over 3,786 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 November 2022Restricted Stock Units · traded 16 November 2022 · filed 18 November 2022
- exercised options over 30,467 shares of BridgeBio PharmaSEC Form 418 November 2022Common Stock · traded 16 November 2022 · filed 18 November 2022
- had shares withheld for tax on 10,789 shares of BridgeBio PharmaSEC Form 418 November 2022Common Stock · traded 16 November 2022 · filed 18 November 2022
- ▼ sold on the open market 19,678 shares of BridgeBio PharmaSEC Form 418 November 2022Common Stock · traded 17 November 2022 · filed 18 November 2022
- exercised options over 1,709 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2022Restricted Stock Units · traded 16 August 2022 · filed 18 August 2022
- exercised options over 778 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2022Restricted Stock Units · traded 16 August 2022 · filed 18 August 2022
- exercised options over 24,193 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 August 2022Restricted Stock Units · traded 16 August 2022 · filed 18 August 2022
- exercised options over 26,680 shares of BridgeBio PharmaSEC Form 418 August 2022Common Stock · traded 16 August 2022 · filed 18 August 2022
- had shares withheld for tax on 9,227 shares of BridgeBio PharmaSEC Form 418 August 2022Common Stock · traded 16 August 2022 · filed 18 August 2022
- exercised options over 1,710 shares of BridgeBio Pharma (a derivative holding)SEC Form 418 May 2022Restricted Stock Units · traded 16 May 2022 · filed 18 May 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.